Bruker (BRKRP) Cost of Revenue (2010 - 2026)

Bruker has reported Cost of Revenue for 17 years, with the latest figure at $443.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 8.14% year-over-year to $443.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 7.62% YoY), and the FY2025 full-year result was $1.9 billion, up 8.26% from the prior year.
• Cost of Revenue for Q1 2026 stood at $443.6 million, down from $528.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $528.0 million in Q4 2025, with the low at $288.7 million in Q1 2022.
• Historically, Cost of Revenue has averaged $393.9 million across 5 years, with a median of $410.2 million in 2025.
• Annual changes were most pronounced in 2022 — Cost of Revenue changed 0.0% — and 2023, when it rose 23.85%.
• Bruker's Cost of Revenue stood at $342.5 million in 2022, then rose by 23.85% to $424.2 million in 2023, then increased by 14.64% to $486.3 million in 2024, then climbed by 8.57% to $528.0 million in 2025, then slipped by 15.98% to $443.6 million in 2026.
• The last three Cost of Revenue figures came in at $443.6 million (Q1 2026), $528.0 million (Q4 2025), and $481.1 million (Q3 2025), per Business Quant data.